Clinical Trial Update: To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and immunogenicity of an oral whole-cell cholera vaccine (Euvichol) in healthy adult men. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Euvichol Cholera Vaccine (inactivated whole-cell cholera vaccine)

Snippet

Sponsor: EuBiologics Co.,Ltd | Conditions: Prevention Harmful Effects | Phase 1 | Status: COMPLETED